jc
jc

News Center

Check category
/
/
/
Jie Cheng medical original generation of new heart valve intervention in the market

Jie Cheng medical original generation of new heart valve intervention in the market

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-05-06 14:36
  • Views:

(Summary description)

Jie Cheng medical original generation of new heart valve intervention in the market

(Summary description)

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-05-06 14:36
  • Views:
Information

  Jincheng medical new generation of interventional heart valve was approved on May 3, 2017
  Suzhou Jincheng Medical Technology Co., Ltd. independently developed the "J-Valve involved in artificial biological heart valve" in May 3, 2017 by the State Food and Drug Administration approved the listing. This is China's first original and has a leading international intellectual property involved in heart valves, is currently the world's only effective minimally invasive treatment of aortic valve insufficiency or stenosis of the product.

 

X

 

  J-Valve heart valve can be based on cardiac anatomical structure automatically precise positioning, minimally invasive catheter intervention method to replace the aortic disease valve. The original positioning device cleverly solved the valve precision implantation and stable anchoring of these troubled minimally invasive heart valve field for many years the key link, to overcome the interventional valve can not effectively treat aortic valve insufficiency of the world problem. This technique avoids the shortcomings of traditional thoracotomy and conventional interventional valve replacement, which makes the operation time is short, the trauma is small, the postoperative recovery is quick and the complication is less, which provides effective treatment for the elderly and high risk patients.

 

S

 

  J-Valve heart valve is the State Food and Drug Administration's "innovative medical equipment special approval procedures (Trial)" innovative special approval project. The technology from the "National Thousand Program" invited experts and a number of international senior professionals based on years of experience in research and development, is the first time in China to the Western developed countries successfully exported high-end medical technology. J-Valve heart valve market approval fully reflects the country to encourage innovation, promote the implementation of medical equipment localization policy.
  "Suzhou Jie Cheng Medical Technology Co., Ltd." is a completely independent intellectual property rights of the minimally invasive medical technology company, with a number of leading international patented technology. The company was founded in September 2009, the research and development team by the heart surgery experts Zhang Gu and many foreign senior professionals. The company's leading project is the innovative "precision positioning of the heart valve implant system" technology research and development and product production. As one of the members of the Suzhou Industrial Park Lakeshore Medical Planting Industry Research Institute, this achievement of Jacheng Medical has further promoted the development of the research institute.
  Suzhou Industrial Park Lakeside Medical Planting Industry Research Institute is committed to become China's implantation into the medical device business development and development of the booster.

Contact us

这是描述信息

+86-512-63179788(WJ) | +86-512-63036288(SZ)

这是描述信息

Building4-1,Hi-Tech Park, Wujiang, Jiangsu Province, China

C21 Building, 218 Xinghu Street, Suzhou Industrial Park, China

这是描述信息

215200

FOLLOW US

这是描述信息

Mobile Website

这是描述信息

WeChat

Copyright ©  Suzhou Jiecheng Medical Technology Co., Ltd. 

这是描述信息